Spero Therapeutics Provides Tebipenem HBr Program Update Following Type A Meeting with the U.S. Food and Drug Administration
Alignment with the FDA on a regulatory path forward for the continued development of tebipenem…
Month: September 2022
CymaBay Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
NEWARK, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage…
Satsuma Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
South San Francisco, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA),…
SeqLL to Present at the H.C. Wainwright 24th Annual Global Conference
BILLERICA, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:…
Selecta Biosciences to Participate at the H.C. Wainwright 24th Annual Global Investment Conference
WATERTOWN, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology…
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass. and NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc….
Cidara Therapeutics to Present at the 24th Annual H.C. Wainwright Global Investment Conference
SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…
TFF Pharmaceuticals to Participate at The H.C. Wainwright 24th Annual Global Investment Conference
FORT WORTH, Texas, Sept. 06, 2022 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage…
Candel Therapeutics Upcoming Investor Conference Participation
NEEDHAM, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Nasdaq: CADL), a late…
Kala Pharmaceuticals to Present at H.C. Wainwright 24th Annual Global Investment Conference
ARLINGTON, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical…
aTyr Pharma to Present at the H.C. Wainwright 24th Annual Global Investment Conference 2022
SAN DIEGO , Sept. 06, 2022 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a…
TRACON Pharmaceuticals Announces $35 Million Non-Dilutive Debt Financing with Runway Growth Capital
Initial $10 million draw extends cash runway to mid-2023 SAN DIEGO, Sept. 06, 2022 (GLOBE…
Cocrystal Pharma to Participate in the H.C. Wainwright Global Investment Conference
BOTHELL, Wash., Sept. 06, 2022 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that…
Next Generation MicroLead 2.0 Now Available with the SPRINT® PNS System
– Enhanced performance with increased strength – MicroLead 2.0 With >2x the cross-sectional metal as…
Keros Therapeutics to Present at the American Society for Bone and Mineral Research 2022 Annual Meeting
LEXINGTON, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a…
Soleno Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
REDWOOD CITY, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO),…
Tenaya Therapeutics Announces FDA Clearance of Investigational New Drug Application and Initiation of Phase 1 Safety Study for TN-301, an HDAC6 Inhibitor for Heart Failure with Preserved Ejection Fraction
SOUTH SAN FRANCISCO, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ: TNYA),…
Keros Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
LEXINGTON, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a…
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
PHILADELPHIA, Sept. 06, 2022 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology…
Immutep Announces Investigator-Initiated Phase II Trial Evaluating LAG-3 Candidate Eftilagimod Alpha (Efti) in Soft Tissue Sarcoma
Expansion of the efti clinical development pipeline with a new Phase II setting Efti Phase…